Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
about
Suitable parameter choice on quantitative morphology of A549 cell in epithelial-mesenchymal transition.The translation factor eIF5A and human cancer.Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cellsN1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2.Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins.Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.Myc, Oncogenic Protein Translation, and the Role of Polyamines.Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cellsMicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
P2860
Q35693683-CAD40578-0F44-497C-A37A-C0439AC42680Q36519353-BD3617DE-B8A4-4D30-B60D-F2C3CF1948D3Q36734197-7615D31C-60B9-46EE-9E2F-9FB2897FBB68Q37685242-A94CFDE6-4964-4A59-B1EC-C09DA37DC5FBQ38881007-96BDF824-BFD7-49E7-A2D8-C8669AC37AE1Q41576686-5B1BFA4B-0B6C-4989-9E30-26447B614118Q41672712-4E5CFD9B-EB01-45F1-ADE7-E90DD85D8F13Q47790409-5C2A52BF-0FAC-4ED1-8A9D-82D52067BC28Q52655137-09511BEF-9BEF-4EF2-993C-DEDC5F35C734Q55414287-F90D592F-1179-416C-A5F1-83B95F837E61Q57493800-5DF77290-4B04-48A5-A3AC-7D2EE1EAE578Q58800121-C7BE3DAD-D3EF-4F1E-B884-C6AC8804490E
P2860
Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@ast
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@en
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@nl
type
label
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@ast
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@en
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@nl
prefLabel
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@ast
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@en
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@nl
P2093
P2860
P356
P1476
Cisplatin sensitivity is enhan ...... slation initiation factor 5A2.
@en
P2093
Dawei Zheng
Guodong Xu
Guofeng Shao
Huoshun Shi
Qingyun Zhou
Xianning Zhang
Xinbao Shi
P2860
P2888
P356
10.1186/1471-2466-14-174
P577
2014-11-07T00:00:00Z
P5875
P6179
1036341490